HM Payson & Co’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-3,825
Closed -$389K 337
2015
Q4
$389K Sell
3,825
-47,257
-93% -$5.31M 0.02% 236
2015
Q3
$9.11M Buy
51,082
+11,784
+30% +$2.75M 0.49% 60
2015
Q2
$8.73M Sell
39,298
-12,642
-24% -$2.8M 0.43% 68
2015
Q1
$10.3M Sell
51,940
-14,237
-22% -$2.53M 0.52% 57
2014
Q4
$9.47M Buy
66,177
+350
+0.5% +$47.1K 0.47% 63
2014
Q3
$8.64M Buy
65,827
+3,083
+5% +$367K 0.44% 68
2014
Q2
$7.91M Buy
+62,744
New +$8M 0.41% 74

Other funds holding BHC

HM Payson & Co's BHC Position: Q1 2016 in Review

HM Payson & Co sold out of Bausch Health (BHC) in Q1 2016, closing a stake of 3,825 shares — an estimated $389K sold.

HM Payson & Co first reported a position in BHC in Q2 2014 and held it in 7 quarters. The position peaked at $10.3M in Q1 2015. 389 funds tracked by Wall St. Rank hold BHC as of Q1 2016.

  • HM Payson & Co reported no remaining Bausch Health position as of Q1 2016 after selling out during the quarter.
  • HM Payson & Co sold 3,825 Bausch Health shares in Q1 2016, an estimated $389K.
  • HM Payson & Co first reported a position in Bausch Health in Q2 2014 and held it in 7 quarters.
  • HM Payson & Co's Bausch Health position peaked at $10.3M in Q1 2015.
  • 389 funds tracked by Wall St. Rank held Bausch Health as of Q1 2016.

Based on HM Payson & Co's 13F filing for Q1 2016, filed 19 May 2016.